Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion
NYSE:ZEPP

Zepp Health (ZEPP) Stock Price, News & Analysis

Zepp Health logo
$8.98 +0.18 (+1.99%)
Closing price 03:59 PM Eastern
Extended Trading
$9.15 +0.16 (+1.83%)
As of 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Zepp Health Stock (NYSE:ZEPP)

Advanced

Key Stats

Today's Range
$8.57
$9.17
50-Day Range
$8.75
$20.91
52-Week Range
$2.22
$61.85
Volume
73,471 shs
Average Volume
100,540 shs
Market Capitalization
$131.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.28
Consensus Rating
Hold

Company Overview

Zepp Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

ZEPP MarketRank™: 

Zepp Health scored higher than 45% of companies evaluated by MarketBeat, and ranked 595th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zepp Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Zepp Health has a consensus price target of $56.28, representing about 526.4% upside from its current price of $8.99.

  • Amount of Analyst Coverage

    Zepp Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Zepp Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zepp Health is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zepp Health is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zepp Health has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Zepp Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.82% of the float of Zepp Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Zepp Health has a short interest ratio ("days to cover") of 6.64.
  • Change versus previous month

    Short interest in Zepp Health has recently decreased by 5.75%, indicating that investor sentiment is improving significantly.
  • Search Interest

    3 people have searched for ZEPP on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zepp Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zepp Health's insider trading history.
Receive ZEPP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZEPP Stock News Headlines

Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
See More Headlines

ZEPP Stock Analysis - Frequently Asked Questions

Zepp Health's stock was trading at $27.09 at the beginning of the year. Since then, ZEPP stock has decreased by 66.8% and is now trading at $8.9850.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) posted its earnings results on Monday, May, 19th. The company reported ($1.13) EPS for the quarter. The company had revenue of $38.54 million for the quarter. Zepp Health had a negative trailing twelve-month return on equity of 15.00% and a negative net margin of 15.48%.
Read the conference call transcript
.

Zepp Health shares reverse split before market open on Monday, September 16th 2024.The 1-4 reverse split was announced on Friday, September 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Zepp Health (ZEPP) raised $110 million in an IPO on Thursday, February 8th 2018. The company issued 10,000,000 shares at $10.00-$12.00 per share.

Zepp Health's top institutional investors include Allspring Global Investments Holdings LLC (0.32%) and Trivest Advisors Ltd (0.21%).

Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zepp Health investors own include NVIDIA (NVDA), PayPal (PYPL), Arista Networks (ANET), MercadoLibre (MELI), ASML (ASML).

Company Calendar

Last Earnings
5/19/2025
Today
5/21/2026
Next Earnings (Estimated)
5/26/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Computer Hardware
Current Symbol
NYSE:ZEPP
CIK
1720446
Fax
N/A
Employees
1,230
Year Founded
2012

Price Target and Rating

High Price Target
$56.28
Low Price Target
$56.28
Potential Upside/Downside
+526.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.07 million
Net Margins
-15.48%
Pretax Margin
-13.70%
Return on Equity
-15.00%
Return on Assets
-6.07%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.02
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$258.90 million
Price / Sales
0.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$14.61 per share
Price / Book
0.61

Miscellaneous

Outstanding Shares
14,680,000
Free Float
9,395,000
Market Cap
$131.90 million
Optionable
Optionable
Beta
2.00

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:ZEPP) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners